Zum Inhalt

Increased GII.3[P12] norovirus outbreaks and viral whole genome analysis in Beijing, China during 2021 and 2023

  • Open Access
  • 01.12.2025
  • Research
Erschienen in:

Abstract

Background

Norovirus is the predominant pathogen responsible for global acute gastroenteritis outbreaks and sporadic cases. While GII.3[P12] norovirus is typically associated with sporadic cases of acute gastroenteritis, outbreaks caused by this genotype increased sharply in Beijing from 2021 to 2023. This study aimed to characterize the GII.3[P12] norovirus outbreaks in Beijing from August 2021 to July 2023, analyze whole-genome sequences, and infer spread dynamics.

Results

GII.3[P12] outbreaks primarily occurred in winter and spring (90.68%, 107/118), concentrated in urban areas (56.78%, 67/118). Ninety-three outbreaks (78.81%, 93/118) were reported in kindergartens. Person-to-person transmission was the main route, accounting for 99.14% (115/116) of outbreaks with a defined route. The maximum clade credibility tree, constructed from partial viral capsid protein 1 and RNA-dependent RNA polymerase genes, showed that GII.3[P12] strains are clustered into three clades, aligning with analyses of 82 whole-genome sequences. Bayesian inference revealed that the most recent ancestor for the three clades of the maximum clade credibility tree based on whole-genome sequences was 2015.66, 2016.56, and 2017.71, respectively, and urban areas are key transmission hubs. The histo-blood group antigens binding sites were conserved, and there were some unique amino acid mutations in the open reading frame 1 region: clade 1 (V779I/D870G/K1004R/I1057V/I1521V), clade 2 (A21V/S195L/R278K/V779I/A782V/A791V/I850T/P1051S/V1091A/S1571T), and clade 3 (T701I).

Conclusions

Our study identified GII.3[P12] as the dominant strain in norovirus outbreaks in Beijing, China (2021–2023). We obtained 82 whole-genome sequences via next-generation sequencing, revealing amino acid mutation-driven evolution, inferring local transmission dynamics, and providing insights for outbreak control and vaccine development.

Supplementary Information

The online version contains supplementary material available at https://doi.org/10.1186/s13099-025-00756-7.

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
AGE
Acute gastroenteritis
cDNA
Complementary DNA
Ct
Cycle threshold
BSP
Bayesian skyline plot
BSSVS
Bayesian stochastic search variable selection
ESS
Effective sample size
HBGA
Histo-blood group antigens
MCC
Maximum clade credibility
MCMC
Markov chain Monte Carlo
NCBI
National center for biotechnology information
NGS
Next-generation sequencing
NoV
Norovirus
ORF
Open reading frame
RDP
Recombination detection program
RdRp
RNA-dependent RNA polymerase
RT-PCR
Reverse transcription polymerase chain reaction
RT-qPCR
Real-time quantitative polymerase chain reaction
TMRCA
The most recent ancestor
VP1
Viral capsid protein 1

Background

Norovirus (NoV) is the predominant pathogen for outbreaks and sporadic cases of acute gastroenteritis (AGE) globally, associated with 16% (95% CI: 15% − 17%) of AGE worldwide [1] and leading to approximately 685 million cases and 212,000 deaths annually [2, 3]. Additionally, NoV infections result in a direct cost of $4.2 billion in the health system and a social cost of $60.3 billion yearly [4]. NoV primarily spreads through person-to-person contact or ingestion of contaminated food and water. Infectious droplets and aerosols from vomiting can also transmit viruses [5], and a recent study suggested that it may spread via salivary glands [6]. Its low infectious dose and high environmental stability make it prone to outbreaks in crowded places such as kindergartens, hospitals, and nursing homes [7].
NoV is a non-enveloped, single-stranded RNA virus from the Caliciviridae family, with a full genome length of 7.5–7.7 kb that contains three open reading frames (ORFs): ORF1 encodes non-structural proteins related to replication, including RNA-dependent RNA polymerase (RdRp) [8]; ORF2 encodes the viral protein 1 (VP1), which has a variable P2 subregion with binding sites for histoblood group antigens (HBGA) [9]; ORF3 encodes viral protein 2 that increases VP1 stability [10]. HBGA are blood group antigens on the surface of human red blood cells, whose differences in structure and composition determine different blood types, governing NoV binding specificities and driving its evolution [11]. Since most recombination breakpoints are found in the ORF1-ORF2 junction region, a dual-region typing system that combines RdRp and VP1 is recommended. NoV can be divided into multiple genotypes, with GI, GII, GIV, GVIII, and GIX groups infecting humans [12].
Molecular detection methods such as reverse transcription polymerase chain reaction (RT-PCR) and real-time quantitative polymerase chain reaction (RT-qPCR) are currently more commonly used for NoV detection. High-throughput sequencing, including next-generation sequencing (NGS) and third-generation sequencing, has the advantages of being more comprehensive, higher throughput, and covering the whole genome. Viral whole-genome sequencing can help infer transmission dynamics, analyze the evolutionary origins, and enhance the connection between genomic sequences and epidemiological data [1315]. For NoV outbreaks, retrospective analysis of whole-genome sequences can trace new variants and analyze evolutionary characteristics.
VP1 evolution links to intergenotypic recombination and RdRp switching, with low-fidelity/high-activity RdRp elevating mutation rates [16], with the GII.3 exhibiting consistent evolutionary patterns and acquiring epidemic advantage via intergenotypic recombination [17]. Previous research showed that GII.3[P12] usually detected in sporadic cases of AGE [18, 19]. However, the detection rate of GII.3[P12] in outbreaks has increased in recent years, particularly in Beijing, where this strain has become the dominant genotype in NoV outbreaks from 2021 to 2023. Therefore, this study aims to: analyze GII.3[P12]’s epidemiological and evolutionary characteristics, investigate its transmission dynamics, identify drivers of its increased prevalence, and provide an evidence base for NoV outbreaks and vaccine development.

Methods

Research subjects and sample sources

In this study, samples and epidemiological information were collected from the AGE outbreaks surveillance network in Beijing, along with laboratory data, including pathogen detection results, pathogen grouping, and cycle threshold (Ct). AGE cases were defined as patients with diarrhea (≥ three loose stools within 24 h) and/or vomiting (≥ 1 episode). An outbreak was defined as ≥ 3 AGE cases caused by NoV within 72 h that were epidemiologically linked (through close contact or common exposure), with ≥ 2 laboratory-confirmed. All the samples collected were stored at − 80 ℃.

Viral RNA extraction and NoV detection

NoV genomic RNA was extracted from 140 µl of a 10% (w/v) fecal suspension in phosphate-buffered saline using the QIAamp Viral RNA Mini kit (Qiagen, Hilden, Germany) according to the manufacturer’s instructions. Approximately 60 µl of nucleic acid eluent was collected into a nuclease-free tube. Real-time RT-PCR was employed to group pathogens and determine Ct values.
The QIAGEN One-Step RT-PCR kit (Qiagen, Hilden, Germany) was used to amplify the partial VP1 and RdRp regions of NoV, with primers MON432/GISKR for GI and MON431/G2SKR for GII [20, 21]. The obtained sequences were assembled using Seq Man 12.2, and genotypes were determined with NoV Genotyping Tool 2.0 (http://www.rivm.nl/mpf/Norovirus/Genotyping Tool).

Subtypes identification and evolutionary analysis of GII.3[P12] NoV

Sequences with the GII.3[P12] (only one per outbreak) genotyping were selected, capturing their identifiers, sampling times, and regions. Reference sequences were downloaded from the National Center for Biotechnology Information (NCBI). The best nucleotide substitution model was assessed using ModelFinder 2.2.0 [22]. We employed three tree priors (constant-size, Bayesian skyline, and exponential growth) and two clock models (strict and relaxed molecular clock) to calculate marginal likelihoods with path sampling [23] (Table S2, S3). We performed phylogenetic analysis to identify GII.3[P12] subtypes circulating in Beijing, and date the most recent common ancestor (TMRCA) by using BEAST v1.10.4 [24]. Markov chain Monte Carlo (MCMC) chains were iterated 2 × 10⁸ times, sampling every 20,000 steps. After discarding the first 10% as burn-in, the convergence of continuous parameters was evaluated by effective sample size (ESS) in Tracer 1.6, and a value greater than 200 was acceptable. The Maximum Clade Credibility (MCC) tree was visualized using FigTree 1.4.2 [25]. Nucleotide intra-sequence similarity and inter-subtype similarity were computed using BioEdit 7.1.3.

Bayesian geographical analysis of GII.3[P12] NoV

To investigate the spatial dynamics of GII.3[P12] NoV in Beijing, we conducted a phylogeographic analysis using an asymmetric continuous-time Markov chain with a Bayesian stochastic search variable selection (BSSVS) model in BEAST 1.10.4, based on GII.3[P12] sequences clustered into different clades [24, 26]. The regions of these sequences were chosen and coded as discrete states. Phylogeographic analysis, using posterior-simulation estimates, demonstrated that both clade 2 and clade 3 exhibited the best-fit geographical diffusion under the HKY substitution model with a strict molecular clock. The diffusion pathways were summarized using spreaD3 0.9.6 [27].

Acquisition of GII.3[P12] NoV whole-genome sequences

Samples from different evolutionary branches were selected for whole-genome sequencing based on subtype identification results. In each outbreak, the sample with the lowest Ct value was prioritized for testing, but multiple samples might be sequenced to ensure whole-genome acquisition. Viral RNA was extracted from 10% (w/v) stool suspensions using the QIAamp Viral RNA Mini kit (Qiagen, Hilden, Germany). RNA from each stool sample was reverse transcribed using LunaScript® Reverse Transcription SuperMix Kit (New England Biolabs, Ipswich, MA, USA), and complementary DNA (cDNA) was amplified using 22 newly designed overlapping PCR primer sets (Table S1) to cover the whole genome. Each reaction included 12.5 µL Q5® Hot Start High-Fidelity 2× Master Mix (New England Biolabs, Ipswich, MA, USA), 3.0 µL F1(odd number)mix/F2༈even༉mix, 5.9 µL H2O, and 3.6 µL cDNA. After incubating at 98 °C for 30 s to inactivate RNase, each reaction underwent 35 cycles of denaturation at 98 °C for 15 s, annealing at 65 °C for 5 min, and then saved at 4 °C. Amplifications were purified using AMPure XP Beads (Beckman Coulter, Brea, CA, USA) and quantified using the Qubit® 3.0 Fluorometer (Qiagen, Hilden, Germany). Genomic DNA tagging and fragmentation were performed with the Nextera® XT Library Prep Kit (Illumina, San Diego, CA, USA), followed by library amplification using the Nextera® XT Index Kit v2 (Illumina, San Diego, CA, USA). The amplified library was purified, quantified, and combined into one tube, diluted to a final concentration of 1.0 ng/µL. Sequencing was performed on the Illumina MiniSeq platform. Based on the downloaded reference sequences (GenBank accession number: OP901693), the CLC Genomics Workbench 23.0 was used to assemble short reads to obtain the whole-genome sequence. In this study, all nucleotide and amino acid positions were referenced to the same sequence (GenBank accession number: OP901693).
For samples failing to obtain whole-genome sequences via NGS, we selected those with fewer gaps, redesigned primers for gaps, and amplified them with the QIAGEN® OneStep RT-PCR Kit (Qiagen, Hilden, Germany), acquiring the missing sequence fragments through Sanger sequencing.

Analysis of GII.3[P12] NoV whole-genome sequences

The whole-genome sequences of GII.3[P12] NoV downloaded from the NCBI database were used as the reference and integrated with those obtained in this study to form Dataset 3. Information was collected, including sequence identifiers, sampling times, and locations. The optimal nucleotide substitution model was evaluated using ModelFinder 2.2.0. The BEAST 1.10.4 was utilized to construct a MCC Tree for phylogenetic analysis and estimation of TMRCA [24]. BioEdit 7.1.3 was used to calculate the intra-sequence and inter-genotype nucleotide similarities. We constructed maximum likelihood trees to enhance the reliability of our cluster classification, assessing their robustness with 1000 bootstrap replicates. Additionally, to investigate the possibility of intra-genotypic recombination among different clades, we also built trees based on the complete VP1 and RdRp sequences, respectively.
Both the obtained nucleotide sequences and reference strains were translated into amino acid sequences for mutation analysis using MEGA X, and amino acid mutation sites were visualized using WebLogo (https://weblogo.berkeley.edu/logo.cgi).

Statistical analysis

SPSS 19.0 was used to compare differences in season, region, setting, and cases’ gender distribution caused by various subtypes of GII.3[P12] via χ² Test or Fisher’s exact method. The Bonferroni correction was applied for further pairwise comparisons when p < 0.05. All tests were conducted at a significance level of α = 0.05, and results were considered statistically significant if p < 0.05. According to the climatic characteristics of Beijing, the seasons are divided as follows: spring (from March to May), summer (from June to August), autumn (from September to November), and winter (from December to February) [28]. Under the education system in China, the various educational stages are divided as follows: kindergarten (ages 3–6), primary school (ages 6–12, Grades 1–6), and comprehensive schools, which refer to the “nine-year consistent program” schools that includes both primary and junior secondary education (ages 6–15, Grades 1–9). Secondary education is divided into junior secondary (ages 12–15, Grades 7–9) and senior secondary (ages 15–18, Grades 10–12).

Results

GII.3[P12] NoV outbreaks in Beijing

In Beijing, a total of 665 NoV AGE outbreaks were reported from August 2021 to July 2023, of which 343 were genotyped. GII.3[P12] (34.40%, 118/343) was the most dominant. GII.4[P16], GII.4[P31], GII.17[P17], mixed, GII.2[P16] were also prevalent, accounting for 13.12% (45/343), 12.84% (44/343) 8.16% (28/343), 7.30% (25/343), 7.00% (24/343) separately. When analyzed by surveillance year, GII.3[P12] accounted for 40.00% (42/105) genotyped outbreaks in 2021–2022 and 31.93% (76/238) in 2022–2023 (Fig. 1).
Fig. 1
Genotype distribution of NoV outbreaks in Beijing from 2021 to 2023
Bild vergrößern
The MCC tree was constructed based on 118 VP1-RdRp sequences from 118 GII.3[P12] outbreaks (Fig. 2). Phylogenetic analysis revealed three evolutionary clades, with the dominant GII.3[P12] norovirus strains circulating in Beijing clustered in clade 2 and clade 3. Clade 1 contained only one sequence detected in 2021. Clade 2 included sequences from 2021 to 2023, with those detected in 2022 being dominant (62.71%, 37/59). In clade 3, 57 sequences were detected in 2023, with only one in 2022. The internal nucleotide similarity of the 59 sequences in clade 2 was 98.67%–100.00%, that of the 58 sequences in clade 3 was 97.91%–100.00%, and the nucleotide similarity between clade 2 and clade 3 was 96.39%–98.29%. Bayesian inference showed that the TMRCA of clades 1, 2, and 3 was 2011.45, 2013.46, and 2012.17, respectively. In clade 2 and clade 3, the divergence times of the Beijing strains are 2017.14 and 2016.65, respectively.
Fig. 2
MCC tree based on partial RdRp and VP1 genes (526 bp) of GII.3[P12] NoV. (The NoV strains detected in this study were marked with circles: yellow for 2021, blue for 2022, and red for 2023. Reference sequences were download from the NCBI and highly homologous to those obtained in this study. The nucleotide substitution model was HKY + G, the molecular clock model is Strict Clock, and the coalescent prior is Bayesian skyline. The node labels indicate the most recent common ancestor (95% HPD intervals))
Bild vergrößern

Epidemiological characteristics of GII.3[P12] NoV AGE outbreaks

GII.3[P12] NoV outbreaks predominantly occurred in spring (65.26%, 77/118), followed by winter (25.42%, 30/118), summer (8.47%, 10/118), and autumn (0.85%, 1/118). These outbreaks were distributed across 10 districts in Beijing, with 67 (56.78%) in urban areas (Chaoyang, Dongcheng, Fengtai, and Xicheng) and 51 (43.22%) in suburban areas (Changping, Daxing, Fangshan, Jingkai, Shunyi, and Tongzhou). Most GII.3[P12] NoV outbreaks occurred in kindergartens (78.81%, 93/118) and primary schools (18.64%, 22/118), while fewer occurred in comprehensive schools (1.70%, 2/118) and middle schools (0.85%, 1/118). The transmission modes of 116 GII.3[P12] NoV outbreaks were identified: person-to-person transmission was most common (99.14%, 115/116), followed by foodborne transmission (0.86%, 1/116).
Characteristics of outbreaks caused by strains of clade 2 and clade 3 were compared, except for clade 1 (containing only one strain) (Table 1). All clade 2 outbreaks occurred in winter-spring (100%, 59/59), whereas 17.24% (10/58) of clade 3 outbreaks occurred in summer-autumn. Clade 2 outbreaks predominantly occurred in kindergartens (89.83%, 53/59), while clade 3 outbreaks occurred in kindergartens (68.97%, 40/58) and primary schools (27.59%, 16/58) (pseasons= 0.001, psettings = 0.009 and page< 0.001).
Table 1
Comparison of epidemiological characteristics of NoV outbreaks caused by different GII.3[P12] subtypes
Genotype
GII.3[P12]
Clade 2
Clade 3
χ2
P
No. outbreaks
118
59
58
  
Median of cases
8(3–49)
8(3–49)
8(3–37)
  
Season*
     
 Winter and Spring
(December–May of the following year)
107(90.68%)
59(100.00%)
48(82.76%)
 
0.001*
Summer and Autum (June–November)
11(9.32%)
0(0.00)
10(17.24%)
 
Region
     
 Urban
67(56.78%)
31(52.54%)
36(62.07%)
1.085
0.352^
 Suburb
51(43.22%)
28(47.46%)
22(37.93%)
Setting
     
 Kindergarten
93(78.81%)
53(89.83%)
40(68.97%)
 
0.009*
 Primary school
22(18.64%)
5(8.47%)
16(27.59%)
 Other
3(2.55%)
1(1.70%)
2(3.45%)
No. cases
1233
643
568
  
Sex
     
 Female
654(53.04%)
354(54.90%)
287(50.53%)
2.312
0.128^
 Male
579(46.96%)
290(45.10%)
281(49.47%)
Age(years old)
     
 ≤ 5
818(66.34%)
533(82.89%)
283(49.82%)
153.70
< 0.001*
 ≥ 6-≤17
404(32.77%)
103(16.02%)
279(49.12%)
 ≥ 18
11(0.89%)
7(1.09%)
6(1.06%)
* means p for Fisher’s exact test; ^means p for χ2 test

The transmission dynamics of the GII.3[P12] NoV outbreaks

The results of spatiotemporal analysis revealed that from August 2021 to July 2023, the primary migration hubs for clade 2 were Chaoyang (4 out-migrations, 3 in-migrations), Tongzhou (4 out-migrations, 2 in-migrations), and Daxing (2 out-migrations, 2 in-migrations) (Fig. 3A). For clade 3, key transmission centers were Chaoyang (3 out-migrations, 1 in-migration) and Changping (3 out-migrations, 1 in-migration) (Fig. 3B).
Fig. 3
Transmission dynamics of different clades of GII.3[P12] NoV in Beijing. (A) Clade 2. (B) Clade3
Bild vergrößern

Analysis of GII.3[P12] NoV whole-genome sequences in Beijing

We obtained 82 GII.3[P12] NoV whole-genome sequences (7444 bp) from 72 outbreaks, with ORF1 (5049 bp), ORF2 (1647 bp), and ORF3 (757 bp). The MCC tree showed that these sequences were clustered into three clades (2 of clade 1, 38 of clade 2, and 42 of clade 3) (Fig. 4), corresponding to the clustering in the MCC tree based on partial VP1-RdRp sequences. For clade 1, all sequences detected in 2021 and showed the highest sequence similarity to strains from Russia in 2022 (GenBank: OP901693), with nucleotide identities ranging from 98.49% to 98.53%. In clade 2, most sequences (20/38, 52.63%) were detected in 2022, sharing 97.60%–98.10% with strains from Beijing, China in 2018(GenBank: OM373562). For clade 3, all sequences detected in 2023, and showed the highest sequence similarity to strains from Taiwan, China in 2020 (GenBank: ON569431), with nucleotide identities ranging from 98.00% to 100.00%. Among the three clades, nucleotide similarity varied from 96.30% to 96.90% between clades 2 and 3, 96.50% to 96.90% between clades 1 and 2, and 96.90% to 97.10% between clades 1 and 3. Bayesian inference showed that the TMRCA of clades 1, 2, and 3 was 2015.66, 2016.56, and 2017.71, respectively. In clade 1, clade 2 and clade 3, the divergence times of the Beijing strains are 2018.81, 2019.61 and 2019.17, respectively.
Fig. 4
MCC tree based on whole-genome sequences of GII.3[P12] NoV. (The NoV strains detected in this study were marked with circles: yellow for 2021, blue for 2022, and red for 2023. Reference sequences were download from the NCBI and highly homologous to those obtained in this study. The nucleotide substitution model was GTR + G, the molecular clock model is Uncorrelated Relaxed Clock, and the coalescent prior is Bayesian skyline. The node labels indicate the most recent common ancestor (95% HPD intervals))
Bild vergrößern
The 82 whole-genome nucleotide sequences from this study were converted into amino acid sequences for comparison of the VP1 and RdRp genes with reference sequences. The results showed that the three known HBGA binding sites of GII.3 remained conserved (Table 2). In the ORF1 region of GII.3[P12] NoV, 13 amino acid mutations were identified: 3 in P48 gene (aa 1–330), 5 in P22 gene (aa 697–875), 1 in VPg gene (aa 876–1008), 2 in Pro gene (aa 1009–1189), and 2 in RdRp gene (aa 1190–1699) (Table 3). Sequences in clade 1 exhibited 5 amino acid mutations: V779I, D870G, K1004R, I1057V, and I1521V (Fig. 5A). Sequences in clade 2 exhibited 8 amino acid mutations: A21V, S195L, R278K, V779I, A782V, A791V, I850T, P1051S, V1091A, and S1571T (Fig. 5B). Sequences in clade 3 exhibited only 1 amino acid mutation: T701I (Fig. 5C).
Table 2
Amino acid differences in the HBGA binding sites of GII.3[P12] NoV in different clades
https://static-content.springer.com/image/art%3A10.1186%2Fs13099-025-00756-7/MediaObjects/13099_2025_756_Tab2_HTML.png
The three HBGA binding sites were represented in green (bottom), red (wall), and blue (wall), respectively, with mutated amino acids highlighted in yellow
Table 3.
Amino acid differences in the ORF1 region of GII.3[P12] NoV among different clades
https://static-content.springer.com/image/art%3A10.1186%2Fs13099-025-00756-7/MediaObjects/13099_2025_756_Tab3_HTML.png
The mutated amino acids were highlighted in yellow
Fig. 5
Amino acid mutation sites of ORF1 region in different clades. (A) Amino acid mutation sites in Clade (1) (B) Amino acid mutation sites in Clade (2) (C) Amino acid mutation sites in Clade 3
Bild vergrößern

Discussion

GII.3[P12] NoV has consistently been an important pathogen for sporadic AGE, while being less commonly observed in outbreaks. From 2003 to 2004, it was the dominant strain in pediatric AGE cases across four prefectures in Japan [29]. Similarly, during 2007–2010, it ranked second in the NoV genotype spectrum among hospitalized children with AGE in Seoul, South Korea [30, 31]. In China, studies have shown that GII.3[P12] is becoming an increasingly important pathogen, particularly in cases of AGE among children. Hospital surveillance from 2010 to 2013 showed that in Chongqing, GII.4_Sydney_2012 and GII.3[P12] replaced GII.4_2006b and GII.4_neworleans_2009 as the dominant genotypes [32]. Surveillance of 1,433 children under 5 years old with AGE in Shanghai revealed that GII.3[P12] was the second most common recombinant genotype in 2013 and 2015–2017 (17.96%, 30/167) [33]. However, GII.3[P12] outbreaks surged in Beijing from August 2021 to July 2023, accounting for 34.40% (118/343) of genotyped NoV outbreaks. Specifically, 42 GII.3[P12] NoV outbreaks (42/104, 40.38%) were reported from August 2021 to July 2022, showing a significant increase compared to the last surveillance year (from August 2020 to July 2021) (7.26%, 13/179). Therefore, in this study, we described and compared the epidemiological characteristics of GII.3[P12] NoV outbreaks from August 2021 to July 2023. We obtained whole-genome sequences using NGS and Sanger sequencing to analyze genetic diversity and evolution. Finally, we combined the epidemiological and sequence information to explore the potential transmission dynamics of GII.3[P12] NoV outbreaks in Beijing.
GII.3[P12] NoV became the dominant strain in Beijing outbreaks between August 2021 and July 2023 (34.40%, 118/343), briefly displacing earlier prevalent strains like GII.17 and GII.2. A similar replacement pattern was observed in pediatric fecal surveillance data from Jiangsu Province from 2010 to 2019, with GII.3[P12] showing higher detection rates in 2013, 2015, and 2018 but lower in 2014 and 2016 (corresponding to the emergence of previously dominant strains), while GII.4[P31] did not significantly reduce the detection rate of GII.3[P12], perhaps due to long-term coexistence and equilibrium of GII.4 and GII.3 infections [34]. Additionally, GII.3[P12] NoV outbreaks were concentrated in spring and winter, primarily occurring in densely populated urban kindergartens and schools, consistent with previous reported transmission patterns [3537].
The evolution of NoV is driven by point mutations and genetic recombination [38, 39]. Phylogenetic analysis reveals that GII.3[P12] NoV strains in Beijing were clustered into three evolutionary clades: Clades 2 and 3 are the dominant strains, while clade 1 (a strain from Shunyi in 2021) may represent imported cases requiring further confirmation. We obtained whole-genome sequences for analysis to avoid incorrect clustering due to short sequences in recombination-prone regions [19]. Nucleotide homology analysis indicates high similarity between these strains and those from Taiwan, China (2020) and Russia (2022), demonstrating expanded prevalence and cross-regional transmission patterns by 2022. The MCC tree of the whole genome showed three evolutionary branches (Clades 1, 2, and 3), consistent with the partial VP1-RdRp results, and confirmed the accuracy of using partial sequences for evolutionary analysis. In addition, most major nodes were well supported by bootstrap values from the maximum likelihood tree (>70%) (Fig S1, S2). However, TMRCA analysis revealed that the divergence times of Beijing strains in VP1-RdRp sequences were different with those in whole-genome phylogenies. This probably because partial-sequence trees contained more reference strains, while whole-genome references for GII.3[P12] NoV were limited (only 33 sequences were available in the NCBI database before this study). Another possible reason is that GII.3[P12] NoV whole-genome sequences were not obtained from all outbreak cases. Historically, GII.3 strains have acquired the RdRp from GII.P12 strains through recombination, which may enhance viral environmental adaptability and fitness under selective pressure [40]. In this study, the GII.3[P12] strains in Beijing adhered to the previously described recombination pattern mentioned before, and no recombination was detected between any of the clades (Figs. S3, S4).
Hutson et al. [41] reported the relationship between HBGA and NoV susceptibility, with type O individuals being more susceptible and type B individuals more resistant. The GII.3 HBGA binding sites I, II, and III are aa 357–360, aa 386, and aa 449–450, respectively [42]. Key site analysis identified a D385G mutation near HBGA binding site II in clades 1 and 3, which may affect host susceptibility, while 13 clade-specific mutations in the ORF1 region could enhance viral replication efficiency, potential contributors to dominant strain replacement. Previous studies confirming that mutations at sites 302, 337, 338, 375, and 378 impair binding to HBGA receptors and reduce affinity for A and O blood types [43]. Furthermore, amino acid sites 293–299 are known to disrupt binding to monoclonal antibodies (mAbs) [44]. Additionally, the presence of a positively selected site and three amino acid differences within the conserved motifs of the GII.P16 RdRp suggests that mutations in this region enhance viral fidelity and replication capacity, thereby leading to the emergence of novel variants [45].
Furthermore, COVID-19 control measures (school closures and social restrictions) temporarily suppressed GII.3[P12] NoV transmission, but post-lockdown immunity gaps in susceptible populations (particularly children) may have accelerated outbreaks. In Beijing, 78.81% (93/118) of GII.3[P12] outbreaks occurred in kindergartens, matching national data showing 93.3% of cases were children aged 3 to 7 [46]. This is due to the vulnerable immune systems of young children and high population density in childcare facilities. Bayesian phylogeographic analysis indicated that urban areas with high density and mobility are key transmission hubs for GII.3[P12] NoV.
The molecular epidemiological findings of this study provide insights for future vaccine strategies. First, GII.3[P12] was identified as the dominant genotype in outbreaks in Beijing during 2021 and 2023, providing epidemiological evidence for vaccine strain selection. Second, the conservation of HBGA binding sites suggests that vaccines targeting these epitopes have the potential to induce broad-spectrum neutralizing antibodies against GII.3[P12].
This study has several limitations. The study period coincided with the COVID-19 prevention measures, which may have influenced the results. School closures could have reduced NoV outbreaks, while increased awareness of symptoms like fever and diarrhea might have led to more cases being reported. However, due to the lack of COVID-19 epidemiological data, we cannot assess its impact accurately. Additionally, the self-limiting nature of NoV symptoms may cause reporting biases, affecting the accuracy of the epidemiological analysis.

Conclusions

Our study analyzed the characteristics of GII.3[P12] NoV outbreaks in Beijing from 2021 to 2023 (predominantly occurring in winter-spring, urban kindergartens, and transmitted from person-to-person). Phylogenetic analysis of 82 whole-genome sequences revealed spatiotemporal transmission dynamics (urban areas as the epidemic hub) and identified amino acid mutations in ORF1 region. These findings provide targets for outbreak control (critical periods, regions, and institutions), while also demonstrating that highly conserved HBGA binding sites could serve as broad-spectrum vaccine targets. Furthermore, strain-specific mutations establish a molecular foundation for multivalent vaccine design.

Acknowledgements

We would like to thank the staff of the 16 district Centers for Disease Control and Prevention in Beijing and clinical staff for collecting epidemiological information and samples during the execution of this study.

Declarations

This study was approved by the Ethics Committee of Beijing Center for Disease Control and Prevention, and the requirement for informed consent was waived. The study was conducted in accordance with the Declaration of Helsinki (2013 revision). All data were anonymized before analysis, and personal identifiers were removed to ensure participant privacy. All applied methods were carried out in accordance with relevant guidelines and regulations.
Not applicable.

Competing interests

The authors declare no competing interests.
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Download
Titel
Increased GII.3[P12] norovirus outbreaks and viral whole genome analysis in Beijing, China during 2021 and 2023
Verfasst von
Jiamei Fu
Lingyu Shen
Weihong Li
Yi Tian
Baiwei Liu
Yu Wang
Lei Jia
Zhaomin Feng
Daitao Zhang
Peng Yang
Zhiyong Gao
Quanyi Wang
Publikationsdatum
01.12.2025
Verlag
BioMed Central
Erschienen in
Gut Pathogens / Ausgabe 1/2025
Elektronische ISSN: 1757-4749
DOI
https://doi.org/10.1186/s13099-025-00756-7
1.
Zurück zum Zitat Liao Y, Hong X, Wu A, Jiang Y, Liang Y, Gao J, et al. Global prevalence of Norovirus in cases of acute gastroenteritis from 1997 to 2021: an updated systematic review and meta-analysis. Microb Pathog. 2021;161Pt A:105259.CrossRef
2.
Zurück zum Zitat Pires SM, Fischer-Walker CL, Lanata CF, Devleesschauwer B, Hall AJ, Kirk MD, et al. Aetiology-specific estimates of the global and regional incidence and mortality of diarrhoeal diseases commonly transmitted through food. PLoS ONE. 2015;10(12):e0142927.PubMedPubMedCentralCrossRef
3.
Zurück zum Zitat Lopman BA, Steele D, Kirkwood CD, Parashar UD. The vast and varied global burden of norovirus: prospects for prevention and control. PLoS Med. 2016;13(4):e1001999.PubMedPubMedCentralCrossRef
4.
Zurück zum Zitat Bartsch SM, Lopman BA, Ozawa S, Hall AJ, Lee BY. Global economic burden of norovirus gastroenteritis. PLoS ONE. 2016;11(4):e0151219.PubMedPubMedCentralCrossRef
5.
Zurück zum Zitat Hagbom M, Lin J, Falkeborn T, Serrander L, Albert J, Nordgren J, et al. Replication in human intestinal enteroids of infectious norovirus from vomit samples. Emerg Infect Dis. 2021;27(8):2212–4.PubMedPubMedCentralCrossRef
6.
Zurück zum Zitat Ghosh S, Kumar M, Santiana M, Mishra A, Zhang M, Labayo H, et al. Enteric viruses replicate in salivary glands and infect through saliva. Nature. 2022;607(7918):345–50.PubMedPubMedCentralCrossRef
7.
Zurück zum Zitat Randazzo W, D’Souza DH, Sanchez G, Norovirus. The burden of the unknown. Adv Food Nutr Res. 2018;86:13–53.PubMedCrossRef
8.
Zurück zum Zitat Thorne LG, Goodfellow IG. Norovirus gene expression and replication. J Gen Virol. 2014;95(Pt 2):278–91.PubMedCrossRef
9.
Zurück zum Zitat Hutson AM, Atmar RL, Marcus DM, Estes MK. Norwalk virus-like particle hemagglutination by binding to h histo-blood group antigens. J Virol. 2003;77(1):405–15.PubMedPubMedCentralCrossRef
10.
Zurück zum Zitat Vongpunsawad S, Venkataram Prasad BV, Estes MK. Norwalk virus minor capsid protein VP2 associates within the VP1 shell domain. J Virol. 2013;87(9):4818–25.PubMedPubMedCentralCrossRef
11.
Zurück zum Zitat Cantelli CP, Fumian TM, Malta FC, da Cunha DC, Brasil P, Nordgren J, et al. Norovirus infection and HBGA host genetic susceptibility in a birth community-cohort, Rio de Janeiro, Brazil. Infect Genet Evol. 2020;82:104280.PubMedCrossRef
12.
Zurück zum Zitat Chhabra P, de Graaf M, Parra GI, Chan MC, Green K, Martella V, et al. Updated classification of Norovirus genogroups and genotypes. J Gen Virol. 2019;100(10):1393–406.PubMedPubMedCentralCrossRef
13.
Zurück zum Zitat Eden JS, Rockett R, Carter I, Rahman H, de Ligt J, Hadfield J, et al. An emergent clade of SARS-CoV-2 linked to returned travellers from Iran. Virus Evol. 2020;6(1):veaa027.PubMedPubMedCentralCrossRef
14.
Zurück zum Zitat Rockett RJ, Arnott A, Lam C, Sadsad R, Timms V, Gray KA, et al. Revealing COVID-19 transmission in Australia by SARS-CoV-2 genome sequencing and agent-based modeling. Nat Med. 2020;26(9):1398–404.PubMedCrossRef
15.
Zurück zum Zitat Uddin M, Mustafa F, Rizvi TA, Loney T, Suwaidi HA, Al-Marzouqi AHH, et al. SARS-CoV-2/COVID-19: viral genomics, epidemiology, vaccines, and therapeutic interventions. Viruses. 2020;12(5):526.PubMedPubMedCentralCrossRef
16.
Zurück zum Zitat Mahar JE, Bok K, Green KY, Kirkwood CD. The importance of intergenic recombination in Norovirus GII.3 evolution. J Virol. 2013;87(7):3687–98.PubMedPubMedCentralCrossRef
17.
Zurück zum Zitat Boon D, Mahar JE, Abente EJ, Kirkwood CD, Purcell RH, Kapikian AZ, et al. Comparative evolution of GII.3 and GII.4 norovirus over a 31-year period. J Virol. 2011;85(17):8656–66.PubMedPubMedCentralCrossRef
18.
Zurück zum Zitat Cannon JL, Bonifacio J, Bucardo F, Buesa J, Bruggink L, Chan MC, et al. Global trends in Norovirus genotype distribution among children with acute gastroenteritis. Emerg Infect Dis. 2021;27(5):1438–45.PubMedPubMedCentralCrossRef
19.
Zurück zum Zitat Epifanova NV, Sashina TA, Morozova OV, Oparina SV, Novikova NA. An increase in prevalence of recombinant GII.3[P12] norovirus in sporadic acute diarrhea in children in Nizhny Novgorod, Russia, 2018–2021. Virus Genes. 2022;58(5):467–72.PubMedCrossRef
20.
Zurück zum Zitat Kojima S, Kageyama T, Fukushi S, Hoshino FB, Shinohara M, Uchida K, et al. Genogroup-specific PCR primers for detection of Norwalk-like viruses. J Virol Methods. 2002;100(1–2):107–14.PubMedCrossRef
21.
Zurück zum Zitat Siqueira JA, Linhares Ada C, de Carvalho TC, Aragão GC, Oliveira Dde S, Dos Santos MC, et al. Norovirus infection in children admitted to hospital for acute gastroenteritis in Belém, Pará, Northern Brazil. J Med Virol. 2013;85(4):737–44.PubMedCrossRef
22.
Zurück zum Zitat Kalyaanamoorthy S, Minh BQ, Wong TKF, von Haeseler A, Jermiin LS. Modelfinder: fast model selection for accurate phylogenetic estimates. Nat Methods. 2017;14(6):587–9.PubMedPubMedCentralCrossRef
23.
Zurück zum Zitat Baele G, Lemey P, Bedford T, Rambaut A, Suchard MA, Alekseyenko AV. Improving the accuracy of demographic and molecular clock model comparison while accommodating phylogenetic uncertainty. Mol Biol Evol. 2012;29(9):2157–67.PubMedPubMedCentralCrossRef
24.
Zurück zum Zitat Drummond AJ, Suchard MA, Xie D, Rambaut A. Bayesian phylogenetics with beauti and the BEAST 1.7. Mol Biol Evol. 2012;29(8):1969–73.PubMedPubMedCentralCrossRef
25.
Zurück zum Zitat Sagnelli C, Uberti-Foppa C, Bagaglio S, Cella E, Scolamacchia V, Hasson H, et al. Molecular epidemiology of HIV-1 infection in immigrant population in Northern Italy. Epidemiol Infect. 2020;148:e19.PubMedPubMedCentralCrossRef
26.
Zurück zum Zitat Lemey P, Rambaut A, Drummond AJ, Suchard MA. Bayesian phylogeography finds its roots. PLoS Comput Biol. 2009;5(9):e1000520.PubMedPubMedCentralCrossRef
27.
Zurück zum Zitat Bielejec F, Rambaut A, Suchard MA, Lemey P. Spread: spatial phylogenetic reconstruction of evolutionary dynamics. Bioinf (Oxford England). 2011;27(20):2910–2.
28.
Zurück zum Zitat Ahmed SM, Lopman BA, Levy K. A systematic review and meta-analysis of the global seasonality of Norovirus. PLoS ONE. 2013;8(10):e75922.PubMedPubMedCentralCrossRef
29.
Zurück zum Zitat Phan TG, Kuroiwa T, Kaneshi K, Ueda Y, Nakaya S, Nishimura S, et al. Changing distribution of Norovirus genotypes and genetic analysis of Recombinant GIIb among infants and children with diarrhea in Japan. J Med Virol. 2006;78(7):971–8.PubMedCrossRef
30.
Zurück zum Zitat Chung JY, Han TH, Park SH, Kim SW, Hwang ES. Detection of GII-4/2006b variant and recombinant noroviruses in children with acute gastroenteritis, South Korea. J Med Virol. 2010;82(1):146–52.PubMedCrossRef
31.
Zurück zum Zitat Han TH, Kim CH, Chung JY, Park SH, Hwang ES. Emergence of norovirus GII-4/2008 variant and recombinant strains in Seoul, Korea. Arch Virol. 2011;156(2):323–9.PubMedCrossRef
32.
Zurück zum Zitat Lu QB, Huang DD, Zhao J, Wang HY, Zhang XA, Xu HM, et al. An increasing prevalence of recombinant GII norovirus in pediatric patients with diarrhea during 2010–2013 in China. Infect Genet Evol. 2015;31:48–52.PubMedCrossRef
33.
Zurück zum Zitat Lu L, Zhong H, Xu M, Su L, Cao L, Jia R, et al. Genetic diversity and epidemiology of genogroup II Noroviruses in children with acute sporadic gastroenteritis in Shanghai, China, 2012–2017. BMC Infect Dis. 2019;19(1):736.PubMedPubMedCentralCrossRef
34.
Zurück zum Zitat Fu J, Ai J, Bao C, Zhang J, Wu Q, Zhu L, et al. Evolution of the GII.3[P12] Norovirus from 2010 to 2019 in Jiangsu, China. Gut Pathog. 2021;13(1):34.PubMedPubMedCentralCrossRef
35.
Zurück zum Zitat Dai YC, Hu GF, Zhang XF, Song CL, Xiang WL, Wu XB, et al. Molecular epidemiology of Norovirus gastroenteritis in children in Jiangmen, China, 2005–2007. Arch Virol. 2011;156(9):1641–6.PubMedCrossRef
36.
Zurück zum Zitat Gao Y, Jin M, Cong X, Duan Z, Li HY, Guo X, et al. Clinical and molecular epidemiologic analyses of norovirus-associated sporadic gastroenteritis in adults from Beijing, China. J Med Virol. 2011;83(6):1078–85.PubMedCrossRef
37.
Zurück zum Zitat Li J, Pan H, Xiao W, Hu J, Yuan Z. Epidemiology of confirmed and suspected Norovirus outbreaks in Shanghai, 2010–2014. Chin J Epidemiol. 2015;36(11):1249–52.
38.
Zurück zum Zitat Debbink K, Lindesmith LC, Donaldson EF, Baric RS. Norovirus immunity and the great escape. PLoS Pathog. 2012;8(10):e1002921.PubMedPubMedCentralCrossRef
39.
Zurück zum Zitat Bull RA, Tanaka MM, White PA. Norovirus recombination. J Gen Virol. 2007;88(Pt 12):3347–59.PubMedCrossRef
40.
Zurück zum Zitat Aguilar Rangel M, Dolan PT, Taguwa S, Xiao Y, Andino R, Frydman J. High-resolution mapping reveals the mechanism and contribution of genome insertions and deletions to RNA virus evolution. Proc Natl Acad Sci USA. 2023;120(31):e2304667120.PubMedPubMedCentralCrossRef
41.
Zurück zum Zitat Hutson AM, Atmar RL, Graham DY, Estes MK. Norwalk virus infection and disease is associated with ABO histo-blood group type. J Infect Dis. 2002;185(9):1335–7.PubMedCrossRef
42.
Zurück zum Zitat Tan M, Jiang X. Norovirus gastroenteritis, carbohydrate receptors, and animal models. PLoS Pathog. 2010;6(8):e1000983.PubMedPubMedCentralCrossRef
43.
Zurück zum Zitat Tan M, Huang P, Meller J, Zhong W, Farkas T, Jiang X. Mutations within the P2 domain of Norovirus capsid affect binding to human histo-blood group antigens: evidence for a binding pocket. J Virol. 2003;77(23):12562–71.PubMedPubMedCentralCrossRef
44.
Zurück zum Zitat Yi Y, Wang X, Wang S, Xiong P, Liu Q, Zhang C, et al. Identification of a blockade epitope of human Norovirus GII.17. Emerg Microbes Infect. 2021;10(1):954–63.PubMedPubMedCentralCrossRef
45.
Zurück zum Zitat Zheng GL, Zhu ZX, Cui JL, Yu JM. Evolutionary analyses of emerging GII.2[P16] and GII.4 Sydney [P16] noroviruses. Virus Evol. 2022;8(1):veac030.PubMedPubMedCentralCrossRef
46.
Zurück zum Zitat Lijiao C, Yanhui Y, Shuting Y, Qing Z, Xiangyu K, Hong W, et al. Molecular epidemiological characteristics of GII.3[P12] Norovirus outbreaks in China, 2022–2023. Chin J Experimental Clin Virol. 2025;39(1):27–33.

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Innere Medizin

Lipoprotein(a) erhöht bei Statintherapie: Wie steht es um das kardiovaskuläre Risiko?

Wann ist das Lipoprotein(a) zu hoch? Diese Frage stellte sich ein deutsches Forschungsteam – und analysierte die Risiken durch Lp(a) bei Patienten, die bereits Statine einnehmen.

Adipositas und Vorhofflimmern: Wie hängen sie zusammen?

Adipositas begünstigt die Entstehung von Vorhofflimmern. Die Frage ist, inwieweit dabei direkte oder indirekte, über Begleiterkrankungen vermittelte Effekte im Spiel sind. In einer beim DGK-Kongress vorgestellten Studie wurde versucht, das zu klären.

Mehr als eine Hydrozele

Starke Schmerzen im rechten Hoden führen einen 37-jährigen Mann in die urologische Praxis. An ein Trauma kann sich der Fitnesstrainer nicht erinnern. Es gibt auch keine Hinweise auf eine Harnwegsinfektion, Harnsteine oder eine sexuell übertragbare Erkrankung. Was ist Ihre Verdachtsdiagnose?

Podcast

Warum wir mehr Peritonealdialysen durchführen sollten

Die Peritonealdialyse wird in Deutschland noch selten genutzt, bietet aber unterschätzte Vorteile: mehr Selbstbestimmung, mehr Lebensqualität, schonender für den Kreislauf. Warum wird sie trotzdem so wenig eingesetzt? Expertin Dr. Grit Esser erklärt, was hinter der Bauchfelldialyse steckt, wie Betroffene informierte Entscheidungen treffen können und worauf Hausärztinnen und Hausärzte achten sollten.

Zeitschrift für Allgemeinmedizin, DEGAM

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Bildnachweise
Die Leitlinien für Ärztinnen und Ärzte, Ärztin misst Blutdruck bei adipöser Frau/© DG PhotoStock / stock.adobe.com (Symbolbild mit Fotomodellen), Hoden an einem Schaubild /© Mathias Ernert/ Urologische Klinik/ Universitätsklinikum Mannheim (Symbolbild mit Fotomodellen), ZFA TALKS - Peritonealdialyse/© (M) Jakovo / Getty Images / iStock (Symbolbild mit Fotomodell) Logo: Springer Medizin Verlag GmbH